KB Financial Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$736K Buy
7,150
+17
+0.2% +$1.83K 0.21% 53
2023
Q2
$823K Sell
7,133
-5,155
-42% -$585K 0.23% 50
2023
Q1
$1.31M Sell
12,288
-89
-0.7% -$9.61K 0.38% 22
2022
Q4
$1.37M Sell
12,377
-804
-6% -$82.2K 0.47% 23
2022
Q3
$1.14M Buy
13,181
+1,818
+16% +$162K 0.41% 21
2022
Q2
$1.04M Buy
11,363
+3,866
+52% +$343K 0.36% 21
2022
Q1
$615K Buy
7,497
+268
+4% +$21.1K 0.17% 54
2021
Q4
$554K Buy
+7,229
New +$576K 0.16% 60
2021
Q3
Sell
-2,526
Closed -$196K 419
2021
Q2
$196K Sell
2,526
-310
-11% -$23.1K 0.07% 155
2021
Q1
$209K Buy
+2,836
New +$209K 0.09% 138

Other funds holding MRK

KB Financial Partners's MRK Position: Q3 2023 in Review

KB Financial Partners increased its Merck (MRK) stake by 0.24% in Q3 2023, buying an estimated $1.83K and bringing the position to 7,150 shares worth $736K. The position accounts for 0.21% of the portfolio, ranked #53.

KB Financial Partners first reported a position in MRK in Q1 2021 and has held it in 10 quarters since. The position peaked at $1.37M in Q4 2022. 3,213 funds tracked by Wall St. Rank hold MRK as of Q3 2023.

  • KB Financial Partners held 7,150 shares of Merck worth $736K as of Q3 2023.
  • KB Financial Partners bought 17 Merck shares in Q3 2023, an estimated $1.83K.
  • Merck made up 0.21% of KB Financial Partners's portfolio in Q3 2023, its #53 holding.
  • KB Financial Partners first reported a position in Merck in Q1 2021 and has held it in 10 quarters since.
  • KB Financial Partners's Merck position peaked at $1.37M in Q4 2022.
  • 3,213 funds tracked by Wall St. Rank held Merck as of Q3 2023.

Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.